Management Out of Pocket Cost Pharmaceutical 
CorpStrat
APRIL 30, 2025
But heres the hidden truth: tariffs may quietly drive up the cost of employer-sponsored health benefits, affecting your bottom line and your ability to attract and retain talent. When tariffs are imposed on foreign goods (especially from major suppliers like China, India, or the EU), the cost of these essentials increases.
McDermott Will & Emery Employee Benefits
OCTOBER 17, 2023
Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Higginbotham
APRIL 8, 2025
The decisions can have a ripple effect into other areas, such as: Increased Health Insurance Costs: Premium increases directly impact the budget and total health spending that is dedicated to employee benefit programs and services. Evaluate pharmacy benefit management strategies for cost efficiency. Ready to learn more?
InterWest Insurance Services
AUGUST 15, 2024
As prescription drug costs continue growing and pricey new pharmaceuticals add to health plans’ cost burdens, some carriers are starting to reduce the number of medications they’ll cover and are imposing new barriers to accessing the most expensive ones. On top of it all, pharmaceuticals are getting more expensive.
Griffin Benefits
MARCH 9, 2022
Here are three ways to manage the cost of pharmaceutical benefits. Focus on fundamentals for Rx cost savings. If employers/plan sponsors and their pharmacy benefit managers (PBMs) can’t control the runaway costs for specialty drugs, they can at least slow the cost impact on the pharmacy benefit.
The Workcomp Writer
NOVEMBER 15, 2023
Claimant’s work injury treatment has been limited to pain management, for which he is prescribed Oxycodone, OxyContin, Soma, Ativan, Zoloft, and CBD oil. Claimant filed the Penalty Petition, alleging therein that the law firm employer violated the Act by failing to reimburse him for out-of-pocket costs for medical treatment.
HR Digest
MARCH 24, 2023
The growing rate of individuals diagnosed with Type 1 and Type 2 diabetes is staggering, and so is the cost of treating and managing the disease. Furthermore, the cost of treating and managing the disease has risen to $327 billion. The condition now impacts roughly 1 in 10 individuals.
Expert insights. Personalized for you.
52 
Let's personalize your content